Public Sector Pension Investment Board increased its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 144.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 938,626 shares of the company's stock after acquiring an additional 555,040 shares during the period. Public Sector Pension Investment Board owned about 0.11% of Colgate-Palmolive worth $97,439,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of the stock. B. Riley Wealth Advisors Inc. boosted its holdings in Colgate-Palmolive by 0.8% during the first quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company's stock worth $1,498,000 after buying an additional 138 shares in the last quarter. Hancock Whitney Corp increased its stake in shares of Colgate-Palmolive by 1.3% in the 1st quarter. Hancock Whitney Corp now owns 12,017 shares of the company's stock valued at $1,082,000 after purchasing an additional 151 shares in the last quarter. Citizens Financial Group Inc. RI raised its holdings in Colgate-Palmolive by 12.4% in the 1st quarter. Citizens Financial Group Inc. RI now owns 14,082 shares of the company's stock worth $1,268,000 after purchasing an additional 1,549 shares during the period. LRI Investments LLC acquired a new stake in Colgate-Palmolive in the first quarter valued at approximately $264,000. Finally, Atria Investments Inc increased its position in shares of Colgate-Palmolive by 3.2% in the first quarter. Atria Investments Inc now owns 67,625 shares of the company's stock valued at $6,090,000 after buying an additional 2,115 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Trading Up 0.2 %
Shares of Colgate-Palmolive stock traded up $0.18 during mid-day trading on Thursday, hitting $96.76. The stock had a trading volume of 3,427,657 shares, compared to its average volume of 4,386,802. The firm has a 50-day moving average of $97.61 and a two-hundred day moving average of $98.58. The firm has a market cap of $79.05 billion, a P/E ratio of 27.72, a price-to-earnings-growth ratio of 3.40 and a beta of 0.42. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12-month low of $75.50 and a 12-month high of $109.30.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.
Insider Transactions at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.37% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently issued reports on the company. Redburn Atlantic upgraded Colgate-Palmolive to a "hold" rating in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lifted their target price for the company from $107.00 to $109.00 in a research report on Monday, September 9th. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a research note on Monday, October 28th. TD Cowen cut their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Monday, October 28th. Finally, Piper Sandler assumed coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 target price for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $105.11.
Read Our Latest Stock Analysis on CL
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.